These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28482391)

  • 21. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
    Schuster V; Kreth HW
    Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
    Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
    Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [X-linked lymphoproliferative syndrome type 1 complicated with secondary hemophagocytic lymphohistiocytosis and ileal perforation: case report and literature review].
    Xiao L; Guan XM; Meng Y; Zhao XD; Xian Y; An YF; Yu J
    Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):290-3. PubMed ID: 27055430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
    Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
    J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease.
    Torralba-Raga L; Tesi B; Chiang SCC; Schlums H; Nordenskjöld M; Horne A; Henter JI; Meeths M; Abdelhaleem M; Weitzman S; Bryceson Y
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28184. PubMed ID: 31994322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
    Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
    Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
    Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
    Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of SH2D1A mutations in patients with severe Epstein-Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma.
    Parolini O; Kagerbauer B; Simonitsch-Klupp I; Ambros P; Jaeger U; Mann G; Haas OA; Morra M; Gadner H; Terhorst C; Knapp W; Holter W
    Ann Hematol; 2002 Aug; 81(8):441-7. PubMed ID: 12224001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.
    Palendira U; Low C; Bell AI; Ma CS; Abbott RJ; Phan TG; Riminton DS; Choo S; Smart JM; Lougaris V; Giliani S; Buckley RH; Grimbacher B; Alvaro F; Klion AD; Nichols KE; Adelstein S; Rickinson AB; Tangye SG
    J Exp Med; 2012 May; 209(5):913-24. PubMed ID: 22493517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.
    Yin L; Ferrand V; Lavoué MF; Hayoz D; Philippe N; Souillet G; Seri M; Giacchino R; Castagnola E; Hodgson S; Sylla BS; Romeo G
    Hum Genet; 1999 Nov; 105(5):501-5. PubMed ID: 10598819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice deficient in the X-linked lymphoproliferative disease gene sap exhibit increased susceptibility to murine gammaherpesvirus-68 and hypo-gammaglobulinemia.
    Yin L; Al-Alem U; Liang J; Tong WM; Li C; Badiali M; Médard JJ; Sumegi J; Wang ZQ; Romeo G
    J Med Virol; 2003 Nov; 71(3):446-55. PubMed ID: 12966553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
    Hislop AD; Palendira U; Leese AM; Arkwright PD; Rohrlich PS; Tangye SG; Gaspar HB; Lankester AC; Moretta A; Rickinson AB
    Blood; 2010 Oct; 116(17):3249-57. PubMed ID: 20644117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
    Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
    Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency of the proapoptotic SAP function in X-linked lymphoproliferative disease aggravates Epstein-Barr virus (EBV) induced mononucleosis and promotes lymphoma development.
    Nagy N; Klein E
    Immunol Lett; 2010 May; 130(1-2):13-8. PubMed ID: 20080127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intronic SH2D1A mutation with impaired SAP expression and agammaglobulinemia.
    Recher M; Fried AJ; Massaad MJ; Kim HY; Rizzini M; Frugoni F; Walter JE; Mathew D; Eibel H; Hess C; Giliani S; Umetsu DT; Notarangelo LD; Geha RS
    Clin Immunol; 2013 Feb; 146(2):84-9. PubMed ID: 23280491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a new disease-causing mutation of SH2D1A in a family with X-linked lymphoproliferative disease.
    Erdõs M; Uzvölgyi E; Nemes Z; Török O; Rákóczi E; Went-Sümegi N; Sümegi J; Maródi L
    Hum Mutat; 2005 May; 25(5):506. PubMed ID: 15841490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
    Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
    Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.